A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult Participants
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants
- Status
- RECRUITING
- Phase
- PHASE1
Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Evaluate Adverse Events and Change in Disease Activity of Mirvetuximab Soravtansine-gynx in Adults With Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer in a Real-World Setting
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
- Status
- RECRUITING
- Phase
- PHASE1
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
- Status
- RECRUITING
- Phase
- PHASE2
Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2